Odyssey Therapeutics Q3 EPS $(1.10) Misses $(1.08) Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Misses
Odyssey Therapeutics (NASDAQ:ODTX) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(1.08) by 1.85 percent.
Odyssey Therapeutics (NASDAQ:ODTX) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(1.08) by 1.85 percent.